Results 11 to 20 of about 16,028,191 (346)

Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy? [PDF]

open access: yesInt J Mol Sci, 2023
Follicle-stimulating hormone (FSH), together with luteinizing hormone (LH) and human chorionic gonadotropin (hCG), plays a fundamental role in human reproduction.
Lispi M   +4 more
europepmc   +2 more sources

Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER. [PDF]

open access: yesTher Innov Regul Sci, 2023
The Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) have been leaders in protecting and promoting the U.S.
Ionan AC   +8 more
europepmc   +2 more sources

Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents. [PDF]

open access: yesAntibiotics (Basel), 2022
Background: Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis (Mtb). TB treatment is based on the administration of three major antibiotics: isoniazid, rifampicin, and pyrazinamide. However, multi-drug resistant
Arrigoni R   +5 more
europepmc   +2 more sources

Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective. [PDF]

open access: yesPharmaceuticals (Basel)
Artificial Intelligence (AI) has the disruptive potential to transform patients’ lives via innovations in pharmaceutical sciences, drug development, clinical trials, and manufacturing.
Mirakhori F, Niazi SK.
europepmc   +2 more sources

Comparability Considerations and Challenges for Expedited Development Programs for Biological Products. [PDF]

open access: yesDrugs R D, 2020
Expedited development programs for biological products to be used in the treatment of serious conditions bring about challenges because of the compressed clinical development timeframes.
Schrieber SJ   +8 more
europepmc   +2 more sources

Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials". [PDF]

open access: yesAAPS J, 2019
To guide developers of innovative and generic drug products that contain nanomaterials, the U.S. Food and Drug Administration issued the draft guidance for industry titled: “Drug Products, Including Biological Products, that Contain Nanomaterials” in ...
de Vlieger JSB   +8 more
europepmc   +2 more sources

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis. [PDF]

open access: yesFront Pharmacol, 2018
Biological products for treatment of rheumatoid arthritis usually are cost effective for healthcare systems in Europe, but they are huge financial burden due to the high number of patients and the significant budget impact.
Manova M   +7 more
europepmc   +2 more sources

Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary. [PDF]

open access: yesClin Pharmacol Ther, 2017
This report serves as a summary of a 2‐day public workshop sponsored by the US Food and Drug Administration (FDA) to discuss the safety of drugs and biological products used during lactation.
Wang J   +19 more
europepmc   +2 more sources

Biological Activities of Natural Products

open access: yesMolecules, 2020
Natural products and their biological activities are currently a subject of great interest in the pharmaceutical, health food, and cosmetics industries, and numbers of scientific studies in this field are increasing rapidly [...].
H. Ekiert, A. Szopa
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy